PharmaTelevision - Animal Health JV, PTV News: Mar 09, 2010

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Animal Health JV, PTV News: Mar 09, 2010

Visitors: You are watching a 30 seconds preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Merck & Co. and sanofi-aventis target US$ 19B market - [00:00]

Summary
Transcript
Participants
Company

Merck & Co. and sanofi-aventis target US$ 19B market

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Tibor Papp
Head of Corporate Advisory
PharmaVentures

Dr Papp is an experienced corporate strategy advisor having spent 18 years in the healthcare / life sciences industry in the areas of commercial and operational strategy, investment management, portfolio development, business transformation, licensing / M&A, and risk management. He has advised leading pharmaceutical, medical device and private equity clients about product, market and M&A deal strategies in pharmaceuticals, biotechnology, medical devices, drug delivery systems, and medical supplies globally. Tibor is also an experienced surgeon, with a PhD from the University of Aberdeen and an MBA from the University of Oxford.

Merck & Co.

Merck & Co., Inc., also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. The headquarters of the company is located in Whitehouse Station, New Jersey, an unincorporated area in Readington Township. It was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during World War I and set up as an independent company. It is currently one of the seven largest pharmaceutical companies in the world both by market capitalisation and revenue.

Merck's products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women’s health. And Merck focuses its research on conditions that affect millions of people around the world – diseases like Alzheimer’s, diabetes and cancer – while building strengths in new areas like biologics.

PharmaVentures Ltd

PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:

• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK

sanofi-aventis

Sanofi-aventis, headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary sanofi pasteur).